N/A
Completed N=232
The VA-STRIDE Study
Source: ClinicalTrials.gov NCT00731094 ↗Enrolled (actual)
232
Serious AEs
26.7%
Results posted
Oct 2014
Primary outcomePrimary: Moderate Intensity Physical Activity: Modified Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire — 37; 44 participants
Summary
The purpose of the study was to examine the effectiveness of an expert-system, print-based physical activity (PA) intervention delivered to Veterans receiving primary care at the VA Pittsburgh Healthcare System (VAPHS).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Moderate Intensity Physical Activity: Modified Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire |
37; 44 | — |
| PRIMARY Moderate Intensity Physical Activity: Modified CHAMPS Questionnaire |
52; 49 | — |
| PRIMARY Moderate Intensity Physical Activity: Modified CHAMPS Questionnaire |
52; 49 | — |
| PRIMARY Moderate Intensity Physical Activity: Accelerometer |
24; 21 | — |
| PRIMARY Moderate Intensity Physical Activity: Accelerometer |
24; 21 | — |
| PRIMARY Moderate Intensity Physical Activity: Accelerometer |
24; 21 | — |
| SECONDARY Weight |
95.3; 98.0 | — |
| SECONDARY Weight |
95.3; 98.0 | — |
| SECONDARY Weight |
95.3; 98.0 | — |
| SECONDARY Systolic Blood Pressure (BP) |
126.1; 126.1 | — |
| SECONDARY Systolic BP |
130.0; 129.3 | — |
| SECONDARY Systolic BP |
130.0; 129.3 | — |
| SECONDARY Diastolic BP |
74.4; 75.9 | — |
| SECONDARY Diastolic BP |
74.4; 75.9 | — |
| SECONDARY Diastolic BP |
74.4; 75.9 | — |
| SECONDARY Low-density Lipoprotein (LDL) Cholesterol |
95.3; 96.4 | — |
| SECONDARY LDL Cholesterol |
92.4; 96.8 | — |
| SECONDARY LDL Cholesterol |
92.4; 96.8 | — |
| SECONDARY High-density Lipoprotein (HDL) Cholesterol |
45.4; 43.2 | — |
| SECONDARY HDL Cholesterol |
45.8; 44.3 | — |
| SECONDARY HDL Cholesterol |
45.8; 44.3 | — |
| SECONDARY Triglycerides |
145.8; 144.2 | — |
| SECONDARY Triglycerides |
145.8; 144.2 | — |
| SECONDARY Triglycerides |
145.8; 144.2 | — |
| SECONDARY Health Related Quality of Life (HRQL): Short Form 36 Health Survey Questionnaire (SF-36) Physical Component Summary Measure (PCS) |
44.7; 47.0 | — |
| SECONDARY HRQL: SF-36 PCS |
44.9; 45.1 | — |
| SECONDARY HRQL: SF-36 PCS |
44.9; 45.1 | — |
| SECONDARY HRQL: SF-36 Mental Component Summary Measure (MSC) |
51.6; 53.0 | — |
| SECONDARY HRQL: SF-36 MCS |
53.0; 52.8 | — |
| SECONDARY HRQL: SF-36 MCS |
53.0; 52.8 | — |
| SECONDARY Physical Function: 6-Minute Walking Distance (6MWD) |
435.9; 445.5 | — |
| SECONDARY Physical Function: 6MWD |
457.5; 444.9 | — |
| SECONDARY Physical Function: 6MWD |
457.5; 444.9 | — |
Eligibility Criteria
Inclusion Criteria
- at least 18 years of age at the time of enrollment,
- one or more primary care clinic visits at VAPHS in the 12 months prior to enrollment
- overweight or obese, with a BMI > =25.0 kg/m^2 at the most recent primary care visit prior to enrollment.
Exclusion Criteria
- primary care provider judgment that unsupervised moderate-intensity exercise will place the Veteran at risk of a cardiovascular event, or other safety concern for guided but unsupervised physical activity
- Veteran is nonambulatory or requires assistive devices to ambulate (e.g., wheelchairs, prosthetic legs, canes or walkers),
- Veteran regularly participates in moderate to brisk physical activity 60 minutes or more each week
- current diagnosis of pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and other comorbid conditions deemed to be contraindications for guided, unsupervised physical activity
- self-reported blindness and/or unable to read printed material in English (e.g., a newspaper)
- plans to move from the VAPHS treatment area in the next 12 months
- unable or unwilling to travel to the study site 4 times during the 12-month study period
- VAPHS employee
- current participant in another interventional research study that may confound outcomes
- unable or unwilling to provide signed, informed consent
Data sourced from ClinicalTrials.gov (NCT00731094). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.